Neuronetics (STIM) Shares Outstanding (2016 - 2026)

Neuronetics (STIM) has 11 years of Shares Outstanding data on file, last reported at $69.6 million in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $69.6 million, up 5.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $69.6 million (up 5.72% YoY), and the FY2025 annual result was $69.0 million, up 23.91% from the prior year.
• Shares Outstanding climbed to $69.6 million in Q1 2026 per STIM's latest filing, from $69.0 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $69.6 million in Q1 2026 and troughed at $26.7 million in Q1 2022.
• A 5-year average of $41.7 million and a median of $30.0 million in 2024 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding increased 2.63% in 2022, then surged 125.76% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $27.3 million in 2022, then climbed by 6.69% to $29.1 million in 2023, then jumped by 91.39% to $55.7 million in 2024, then grew by 23.91% to $69.0 million in 2025, then increased by 0.85% to $69.6 million in 2026.
• Business Quant data shows STIM's Shares Outstanding at $69.6 million in Q1 2026, $69.0 million in Q4 2025, and $68.4 million in Q3 2025.